Amphetamine, past and present – a pharmacological and clinical perspective

Long-Term Effectiveness and Safety of Lisdexamfetamine Dimesylate in School-Aged Children with Attention-Deficit/Hyperactivity Disorder

(2016) Robert L. Findling et al.   CNS SPECTRUMS

Long-Term Safety and Effectiveness of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

(2016) Richard Weisler et al.   CNS SPECTRUMS

Lisdexamfetamine Dimesylate: A Prodrug Stimulant for the Treatment of ADHD in Children and Adults

(2016) Gregory Mattingly   CNS SPECTRUMS

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder

(2012) Sharon B Wigal et al.   Child and Adolescent Psychiatry and Mental Health

Animal models to guide clinical drug development in ADHD: lost in translation?

(2011) Jeffery R Wickens et al.   BRITISH JOURNAL OF PHARMACOLOGY

Intranasal versus Oral Administration of Lisdexamfetamine Dimesylate

(2011) James C. Ermer et al.   CLINICAL DRUG INVESTIGATION

Cost of disorders of the brain in Europe 2010

(2011) Anders Gustavsson et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The size and burden of mental disorders and other disorders of the brain in Europe 2010

(2011) H.U. Wittchen et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day

(2011) Sharon B Wigal et al.   Child and Adolescent Psychiatry and Mental Health

Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design

(2010) Timothy Wigal et al.   Behavioral and Brain Functions

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD

(2010) Sandra JJ Kooij et al.   BMC Psychiatry

Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD

(2010) Rachel E Dew et al.   EXPERT OPINION ON PHARMACOTHERAPY

Lisdexamfetamine Dimesylate: Linear Dose-Proportionality, Low Intersubject and Intrasubject Variability, and Safety in an Open-Label Single-Dose Pharmacokinetic Study in Healthy Adult Volunteers

(2010) James Ermer et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Monoaminergic Psychomotor Stimulants: Discriminative Stimulus Effects and Dopamine Efflux

(2010) R. I. Desai et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Regulation of monoamine transporters: Role of transporter phosphorylation

(2010) Sammanda Ramamoorthy et al.   PHARMACOLOGY & THERAPEUTICS

Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine

(2010) Pennick   Neuropsychiatric Disease and Treatment

The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults

(2009) Jadwiga Najib   CLINICAL THERAPEUTICS

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis

(2009) Stephen V. Faraone et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Safety of stimulant treatment in attention deficit hyperactivity disorder: part I

(2009) Richard Lawrence Merkel et al.   Expert Opinion On Drug Safety

Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

(2009) Lenard A. Adler et al.   JOURNAL OF CLINICAL PSYCHIATRY

Short-Term Effects of Lisdexamfetamine Dimesylate on Cardiovascular Parameters in a 4-Week Clinical Trial in Adults With Attention-Deficit/Hyperactivity Disorder

(2009) Lenard A. Adler et al.   JOURNAL OF CLINICAL PSYCHIATRY

Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse

(2009) DR Jasinski et al.   JOURNAL OF PSYCHOPHARMACOLOGY

A Closer Look at Amphetamine-Induced Reverse Transport and Trafficking of the Dopamine and Norepinephrine Transporters

(2009) S. D. Robertson et al.   MOLECULAR NEUROBIOLOGY

The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety

(2009) D.J. Heal et al.   NEUROPHARMACOLOGY

The spontaneously hypertensive rat model of ADHD – The importance of selecting the appropriate reference strain

(2009) Terje Sagvolden et al.   NEUROPHARMACOLOGY

America’s First Amphetamine Epidemic 1929–1971

(2008) Nicolas Rasmussen   AMERICAN JOURNAL OF PUBLIC HEALTH

Metabolism, Distribution and Elimination of Lisdexamfetamine Dimesylate

(2008) Suma M Krishnan et al.   CLINICAL DRUG INVESTIGATION

Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers

(2008) DR Jasinski et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Fast uptake and long-lasting binding of methamphetamine in the human brain: Comparison with cocaine

(2008) Joanna S. Fowler et al.   NEUROIMAGE

Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: Neurotoxic and therapeutic implications

(2008) Annette E. Fleckenstein et al.   NEUROPHARMACOLOGY

New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD

(2008) D.J. Heal et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Effect of Lisdexamfetamine Dimesylate on Parent-Rated Measures in Children Aged 6 to 12 Years With Attention-Deficit/Hyperactivity Disorder: A Secondary Analysis

(2008) Frank A. Lopez et al.   POSTGRADUATE MEDICINE

Trafficking of Vesicular Neurotransmitter Transporters

(2008) Hao Fei et al.   TRAFFIC